Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Robert Scheinberg

Sports Medicine Dallas, TX Medical Doctor

NPI 1053320010 CMS profile 320110

8210 Walnut Hill Ln Ste 130, Dallas, TX 75231

Open in the dashboard

General payments

$2,194,289

111 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Robert Scheinberg of Dallas, TX is reported in the CMS Open Payments database as having received $2,194,289 across 111 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $891 23
2024 General $879 21
2023 General $1,905,350 12
2022 General $1,994 16
2021 General $2,617 8
2020 General $598 6
2019 General $281,960 25

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Robert Scheinberg
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Robert Scheinberg were reported at $891. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year Robert Scheinberg Sports Medicine median Middle half National median
2019 $281,960 $1,176 $199–$4,249 $163
2020 $598 $708 $96–$2,890 $114
2021 $2,617 $1,213 $152–$3,994 $132
2022 $1,994 $1,230 $159–$3,998 $149
2023 $1,905,350 $584 $146–$2,836 $160
2024 $879 $628 $163–$3,168 $164
2025 $891 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Arthrex, Inc. $2,185,108 18 payments
  2. Pylant Medical $4,775 7 payments
  3. Stryker Corporation $3,007 24 payments
  4. Ferring Pharmaceuticals Inc. $386 19 payments
  5. Sanofi-Aventis U.S. LLC $211 10 payments
  6. Vericel Corporation $155 2 payments
  7. Vertex Pharmaceuticals Incorporated $126 6 payments
  8. Smith+Nephew, Inc. $119 4 payments
  9. Merck Sharp & Dohme Corporation $81 5 payments
  10. Cumberland Pharmaceuticals, Inc. $75 4 payments
  11. Other $245 12 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $2,176,675 5 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $7,000 1 payment
  3. Education $4,501 3 payments
  4. Food and Beverage $3,208 91 payments
  5. Travel and Lodging $2,405 10 payments
  6. Consulting Fee $500 1 payment
Products named General payments · program years 2019–2025
  1. DISTAL EXTREMITIES IMPLANTS SCREWS METAL COMPRESSION SCREWS $271,675 4 payments
  2. DISTAL EXTREMITIES INSTRUMENTS DEVICE SPECIFIC INSTRUMENTS COMPRESSION SCREWS $142,782 2 payments
  3. DISTAL EXTREMITIES IMPLANTS SCREWS BIO COMPRESSION SCREWS $142,782 2 payments
  4. KNEE & HIP INSTRUMENTS OTHER INSTRUMENTS BIO COMPRESSION SCREWS $128,894 2 payments
  5. KNEE & HIP IMPLANTS OTHER BIO COMPRESSION SCREWS $128,894 2 payments
  6. MAKO $1,503 5 payments
  7. ICONIX $477 6 payments
  8. EUFLEXXA $386 19 payments
  9. SYNVISC-ONE $198 9 payments
  10. ALPHAVENT $178 3 payments
  11. Other $2,075 56 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

131

Median for Orthopedic Surgery: 203

Drug cost

$1,574

Median for Orthopedic Surgery: $1,433

Branded share of claims

55.7%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 73 $907
Celecoxib Generic 15 $452
Methylprednisolone Generic 12 $119
Tramadol Hcl Generic 12 $49
Meloxicam Generic 19 $47

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 71 billing codes

Paid by Medicare

$172,255

Of which drugs: $25,140

Medicare patients

403

Average age 73

Services billed

23,549

231 women, 172 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 70%
High blood pressure 69%
Ischemic heart disease 23%
Diabetes 20%
Depression 19%
Osteoporosis 16%
Atrial fibrillation 15%
Chronic kidney disease 12%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg J7325 Office 49 3,184 $21,736
Injection, methylprednisolone acetate, 1 mg J1010 Office 170 18,581 $1,888
Injection, methylprednisolone acetate, 40 mg J1030 Office 37 88 $407

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

111 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record